Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
10,175 total articles
EchoStar CORP's Chief Legal Officer Dean Manson reported the sale of 19,031 Class A shares on March 5, 2026, for about $2.18 million, according to an SEC Form 4. The transaction occurred the same day Manson exercised options to acquire 21,631 shares at $14.04 per share. The stock has risen 291% over the past year but declined 7.4% in the prior week…
Item Second Irr. Trust FBO Kyle R. Westphal, identified as a ten percent owner of Vertex, Inc. (NASDAQ: VERX), sold 10,000 shares of Class A Common Stock on March 9, 2026, for $150,477 at a weighted average price of $15.0477. The transaction reduced a holding that still stands at 1,221,100 shares. The sale occurs as VERX trades at $14.94, down 54% …
Broadridge Financial Solutions Chief Executive Timothy C. Gokey bought 5,300 shares on March 6, 2026, in a transaction valued at $1,030,794. The move coincides with the company’s announced agreement to acquire CQG and a mix of analyst reactions that include reiterated and upgraded Buy ratings alongside trimmed price targets.
Jennifer Baldock, Chief Admin & Dev Officer of Surgery Partners, sold 10,082 shares on March 6, 2026 to meet tax obligations tied to a restricted stock vesting, while receiving 106,207 restricted shares the prior day. The company has recently reported results and guidance that prompted analyst price-target reductions and completed a sizable acquisi…
Surgery Partners Chief Executive Officer Jason Eric Evans sold 11,462 shares on March 6, 2026, for $13.79 per share, generating proceeds of $158,060 to cover tax liabilities tied to restricted stock vesting. The transactions followed a grant of 278,106 restricted shares on March 5, 2026, and leave Evans with 940,786 shares outstanding. The stock is…
Surgery Partners CFO David T. Doherty disposed of 14,574 shares on March 6, 2026, to meet tax withholding tied to newly vested restricted stock. The sale came as the company's shares trade close to a 52-week low, after a recent weekly decline. Doherty still holds 88,803 shares after the transaction. Separately, the company expanded its ambulatory f…
Arthur J. Gallagher & Co. Vice President Hudson Scott R. completed offsetting equity transactions on March 6, 2026, selling 3,800 shares for $864,766 and exercising options to acquire 3,800 shares at $79.59 for $302,442. Following the trades, Hudson holds 85,920 shares directly and 411.467 shares indirectly through the Gallagher 401(k) plan; he als…
Jane Prior, Chief Marketing Officer of The Vita Coco Company, Inc. (NASDAQ: COCO), executed a set of transactions on March 5, 2026, that included the sale of common stock worth roughly $2.6 million and the exercise of employee stock options. The trades coincided with analyst model updates following the company’s fourth-quarter results and a board a…
WhiteHorse Finance director John Bolduc bought $119,710 of the company’s common shares in transactions filed on Form 4, executed on March 5 and 6, 2026. The purchases were recorded at prices between $7.11 and $7.25 per share and bring Bolduc’s direct and indirect holdings to 272,032 shares. The trades coincide with a recent 10.4% one-week stock gai…
Mike Zoi, who holds a roughly 10% stake in Motorsport Games Inc. (MSGM), sold 144,844 Class A shares across three transactions between March 5 and March 9, 2026, for proceeds totaling $665,138. The disposals were executed under a Rule 10b5-1 plan put in place on December 31, 2025; Zoi continues to indirectly own 1,191,420 shares through Driven Life…
Joel Bender, director and president of Cactus, Inc. (WHD), sold 63,963 shares of Class A common stock on March 5, 2026, for $50.74 per share, a transaction totaling $3,245,482. The company delivered a better-than-expected Q4 2025, but its stock fell in after-hours trading amid broader market concerns and company-specific headwinds. Analysts adjuste…
Sara Kelly, Executive Vice President and Chief Partner Officer at Starbucks Corporation, sold 2,500 shares on March 5, 2026, under a pre-arranged Rule 10b5-1 plan for $242,800. After the sale she directly owns 59,608.5548 shares. The stock has risen to $99.77 and is up 20.68% over six months as the company navigates a mixed first-quarter fiscal 202…
Hamilton James C., chief medical officer at Arrowhead Pharmaceuticals (ARWR), sold 10,000 shares on March 5, 2026 under a pre-arranged 10b5-1 plan for a total of $641,900. The transaction occurred as the company reported Q1 fiscal 2026 results that beat expectations, while analysts and platform analysis flagged valuation and guidance concerns that …
Tesla Chief Financial Officer Vaibhav Taneja sold 2,264.5 shares of Tesla stock on March 6, 2026, for roughly $899,076, while restricted stock units vested for him the prior day. The transactions, disclosed in a Form 4 filing with the SEC, altered his direct and indirect holdings. The sale coincided with shares trading near $398.68, a level about 5…
Brewer Brady, Starbucks' CEO, International, sold 1,641 shares on March 5, 2026 under a pre-arranged 10b5-1 plan, generating $159,373. The transaction leaves Brady with 86,604.502 shares. The stock trades near fair value while Starbucks reported Q1 fiscal 2026 earnings that missed EPS estimates but beat revenue forecasts, and the company is expandi…
Myriad Genetics CEO Samraat S. Raha bought 40,000 shares on March 9, 2026, spending $199,844 at prices between $4.97 and $5.00. The transaction raises Raha's direct holdings to 493,104 shares as the company's stock trades near $4.81 after a year-long 52.75% drop. Myriad reported a fourth-quarter 2025 earnings and revenue beat, and analysts cited by…
Kathryn E. Falberg, a director at Trade Desk, Inc. (NASDAQ: TTD), sold $4,655,112 worth of Class A Common Stock in two transactions on March 5, 2026. The sales, split between shares she owned personally and shares held in a family trust, occurred at weighted average prices of $30.45 and $30.48. The stock has since fallen to $28.56, reflecting a 56%…
Q2 Holdings General Counsel Michael S. Kerr sold 12,375 shares of common stock in two transactions in March 2026, generating proceeds of $638,417. One trade was made under a Rule 10b5-1 plan and the other was a company-mandated sale to cover tax liabilities tied to RSU vesting. After the trades Kerr retains direct ownership of 47,227 shares. The sa…
Lion Fund, L.P., a roughly 10% owner of Biglari Holdings Inc (NYSE: BH), bought 3,320 shares of Class B common stock on March 9, 2026, paying a weighted average of $301.06 per share for a total of $999,519, according to a Form 4 filed with the SEC. The purchase occurred while the stock was down 8.81% over the prior week and trading at $306.76.
Affiliated Managers Group Inc. (AMG) saw a series of insider transactions by President and COO Thomas M. Wojcik in early March 2026, including an 8,000-share sale on March 6 worth roughly $2.29 million and multiple vesting-related movements on March 5. The trades coincided with a 10% share-price decline over the prior week while the firm reported f…
Venture Global, Inc. Senior Vice President and Chief Accounting Officer Blake Sarah sold 330,700 shares of Class A common stock across transactions on March 5 and March 9, 2026, generating roughly $3.95 million in proceeds. The sales, executed at prices between $11.5665 and $13.0035 per share, followed an exercise of options to acquire the same num…
Fastly Inc. CEO Compton Charles Lacey III sold 36,694 shares of Class A Common Stock on March 5, 2026, in two transactions totaling about $759,019 under a pre-arranged Rule 10b5-1 plan adopted August 27, 2025. The stock has climbed sharply over the past year and is trading close to its 52-week high. The company recently reported quarterly results t…
Alaleh Nouri, Executive Vice President of PROCEPT BioRobotics (PRCT), sold 6,892 shares on March 6, 2026, for roughly $163,353, after receiving a separate zero-valued share allotment and a grant of options the prior day. The company reported a revenue increase but remains unprofitable, and recent fourth-quarter results prompted a revision to 2026 g…
Zachary D. Kravitz, Northwest Natural Holding Co's vice president of regulatory affairs and resource planning, reported two separate stock transactions on March 5, 2026: a small open-market sale and a larger transfer to cover tax withholding related to vesting equity. The trades occurred while Northwest Natural's shares were trading close to their …
Director Arve Hanstveit reported sales totaling $534,399 of Energy Recovery, Inc. (NASDAQ: ERII) common stock in two Form 4 transactions filed with the U.S. Securities and Exchange Commission. The sales, executed March 5 and March 6, 2026, reduced his direct holdings to 575,220 shares. The insider move comes amid a 23% share-price decline over six …
